Literature DB >> 21114686

Evolution of urological imaging.

Anton J Bueschen1, Mark E Lockhart.   

Abstract

The evolution of urological imaging has had a major impact on the diagnosis and treatment of urological diseases since the discovery of the X-ray by Roentgen in 1895. Early developments included plain films of the abdomen, retrograde urographic techniques, development of contrast media, excretory urography, renal mass puncture, renal angiography, cystography and nuclear medicine procedures. These procedures led to the maturation of the specialties of diagnostic radiology and urology, and the development of the subspecialties of pediatric urology and urological radiology during the first seven decades of the 20th century. Subsequently, many imaging advances have occurred leading to changes in diagnosis and management of urological patients. Ultrasound and cross-sectional imaging technologies (computed tomography and magnetic resonance imaging) are increasingly applied in urological evaluation, treatment and surveillance. Current developments include dual energy computed tomography, positron emission tomography computed tomography, renal donor and renal transplant imaging, prostate magnetic resonance imaging, and microbubble contrast enhanced ultrasound. Imaging advances will continue. It is the responsibility of all physicians to assess the advantages of new developments while weighing those advantages against the additional radiation exposure and the costs associated with new procedures.
© 2010 The Japanese Urological Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21114686     DOI: 10.1111/j.1442-2042.2010.02677.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  8 in total

1.  New developed urological protocols for the Uro Dyna-CT reduce radiation exposure of endourological patients below the levels of the low dose standard CT scans.

Authors:  M-C Rassweiler; R Banckwitz; C Koehler; B Mueller-Allissat; M-S Michel; A Häcker; M Ritter
Journal:  World J Urol       Date:  2013-10-30       Impact factor: 4.226

2.  Doppler ureteric jet in urogenital prolapse.

Authors:  Tsia-Shu Lo; Cheng-Yu Long; Yi-Hao Lin; Ho-Hsiung Lin
Journal:  Int Urogynecol J       Date:  2011-09-17       Impact factor: 2.894

3.  Drainage-related ultrasonography (DRUS): a novel technique for discriminating obstructive and nonobstructive hydroureters in children.

Authors:  Abdol-Mohammad Kajbafzadeh; Mehrzad Mehdizadeh; Zahra Aryan; Maryam Ebadi; Shadi Abdar Esfahani; Laleh Montaser-Kouhsari; Azadeh Elmi; Saman Shafaat Talab; Zhina Sadeghi
Journal:  J Ultrasound       Date:  2014-10-11

4.  The Urological Dyna-CT: ex vivo feasibility study of interventional cross-sectional imaging in the endourological operation room.

Authors:  M S Michel; M Ritter; H Wertz; S Schönberg; A Häcker; G Weisser
Journal:  World J Urol       Date:  2012-09-21       Impact factor: 4.226

Review 5.  CT angiography for surgical planning in face transplantation candidates.

Authors:  S Soga; B Pomahac; N Wake; K Schultz; R F Prior; K Kumamaru; M L Steigner; D Mitsouras; J Signorelli; E M Bueno; D S Enterline; F J Rybicki
Journal:  AJNR Am J Neuroradiol       Date:  2012-08-09       Impact factor: 3.825

6.  [The urological Dyna-CT. Urological cross-sectional imaging on a newly developed urological intervention table].

Authors:  M S Michel; M Ritter; S Schönberg; A Häcker; G Weisser
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

7.  Mn porphyrins as novel molecular magnetic resonance imaging contrast agents.

Authors:  Vladimir Mouraviev; Talaignair N Venkatraman; Artak Tovmasyan; Masaki Kimura; Matvey Tsivian; Vladimira Mouravieva; Tom J Polascik; Haichen Wang; Timothy J Amrhein; Ines Batinic-Haberle; Christopher Lascola
Journal:  J Endourol       Date:  2012-10-04       Impact factor: 2.942

8.  Novel contrast-enhanced ultrasound imaging in prostate cancer.

Authors:  Martijn Smeenge; Massimo Mischi; M Pilar Laguna Pes; Jean J M C H de la Rosette; Hessel Wijkstra
Journal:  World J Urol       Date:  2011-08-17       Impact factor: 4.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.